Table 3. Prevalence of bisphosphonate-related osteonecrosis of the jaw according to drug type, duration of administration, and CTx level.
*Statistically significant difference at P<.05, BRONJ: bisphosphonate-related osteonecrosis of the jaw, CTx: C-terminal telopeptide, Alen: alendronate, Iban: iIbandronate, Rise: risedronate